DUBLIN--(BUSINESS WIRE)--Jan 4, 2023--

The “Rheumatoid Arthritis Therapeutics: Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering.

The global market for Rheumatoid Arthritis Therapeutics estimated at US$25.4 Billion in the year 2020, is projected to reach a revised size of US$34 Billion by 2027, growing at a CAGR of 4.3% over the analysis period 2020-2027.

Pharmaceuticals, one of the segments analyzed in the report, is projected to record 4.1% CAGR and reach US$14.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Biopharmaceuticals segment is readjusted to a revised 4.4% CAGR for the next 7-year period.

The U.S. Market is Estimated at $6.9 Billion, While China is Forecast to Grow at 7.4% CAGR

The Rheumatoid Arthritis Therapeutics market in the U.S. is estimated at US$6.9 Billion in the year 2020. China, the world’s second largest economy, is forecast to reach a projected market size of US$7 Billion by the year 2027 trailing a CAGR of 7.3% over the analysis period 2020 to 2027.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.1% and 3.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.9% CAGR.

Select Competitors (Total 23 Featured) -

• AbbVie, Inc.
• Amgen, Inc.
• Boehringer Ingelheim GmbH
• Bristol-Myers Squibb Company
• F. Hoffmann-La Roche AG
• Johnson & Johnson
• Novartis International AG
• Pfizer, Inc.
• Regeneron Pharmaceuticals, Inc.
• UCB SA

What’s New for 2022?

• Global competitiveness and key competitor percentage market shares
• Market presence across multiple geographies - Strong/Active/Niche/Trivial
• Online interactive peer-to-peer collaborative bespoke updates
• Access to digital archives and Research Platform
• Complimentary updates for one year

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

• Influencer Market Insights
• World Market Trajectories
• Impact of Covid-19 and a Looming Global Recession
• Rheumatoid Arthritis Therapeutics - Global Key Competitors Percentage Market Share in 2022 (E)
• Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

For more information about this report visit https://www.researchandmarkets.com/r/yjy4m1

View source version on businesswire.com:https://www.businesswire.com/news/home/20230104005826/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2023.

PUB: 01/04/2023 12:22 PM/DISC: 01/04/2023 12:21 PM

http://www.businesswire.com/news/home/20230104005826/en